Symbol="YS"
AssetType="Common Stock"
Name="YS Biopharma Co. Ltd. Ordinary Shares"
Description="YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company is headquartered in Beijing, China."
CIK="1946399"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="TECHNOLOGY"
Industry="GENERAL"
Address="NONE"
FiscalYearEnd="March"
LatestQuarter="None"
MarketCapitalization="None"
EBITDA="None"
PERatio="None"
PEGRatio="None"
BookValue="None"
DividendPerShare="None"
DividendYield="None"
EPS="None"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="0"
ReturnOnEquityTTM="0"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="0"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="None"
num_52WeekHigh="18.44"
num_52WeekLow="1.12"
num_50DayMovingAverage="0"
num_200DayMovingAverage="0"
SharesOutstanding="0"
DividendDate="None"
ExDividendDate="None"
symbol="YS"
open="1.33"
high="1.35"
low="1.32"
price="1.33"
volume="87408.00"
latest_trading_day="2023-07-12"
previous_close="1.36"
change="-0.03"
change_percent="-2.2059%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="21"
trend_strength="nan"
buying_signal="Weak Sell Signal"
volume_analysis="Oversold"
value_analysis="Undervalued"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="1054843"
Change_recent_avg="-0.15"
Delta_recent_avg="0.41"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="-3.82"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="21"
image_negative_thumbnail_id_1="1158"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0192.jpeg"
image_negative_thumbnail_id_2="132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0044.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="578"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_positive_thumbnail_id_1="663"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0045.jpeg"
image_positive_thumbnail_id_2="675"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
